75ºF

Ann Arbor-based NeuMoDx expands footprint, increases COVID-19 testing production

A lab technician begins semi-automated testing for COVID-19 at Northwell Health Labs on March 11 in Lake Success, New York. (Photo by Andrew Theodorakis/Getty Images)
A lab technician begins semi-automated testing for COVID-19 at Northwell Health Labs on March 11 in Lake Success, New York. (Photo by Andrew Theodorakis/Getty Images) (Getty Images)

ANN ARBOR, Mich. – Ann Arbor-based molecular system solutions company NeuMoDx, Inc. will double the size of its current location and triple its production of COVID-19 tests.

Located in the Eisenhower Commerce Center, NeuMoDx switched gears to meet the demand of the coronavirus pandemic by producing COVID-19 tests for hospital and clinical laboratories around the world.

Previously, the company focused on instruments and tests for blood-borne viruses including HIV and Hepatitis B, and infections like Chlamydia and Gonorrhea.

✉  Like what you’re reading? Sign up for our email newsletter here!

The expansion brings the company’s footprint to almost 75,000 square feet and allows it to ramp up COVID-19 test production by at least 300%.

“NeuMoDx is thrilled with our expansion in Ann Arbor’s Southside,” NeuMoDx Chief Commercial Officer Daniel Harma said in a statement.

“Oxford Companies made the leasing process easy and enjoyable. With this huge increase in square footage, NeuMoDx will have the capacity to increase our production of much-needed testing supplies to hospitals and labs around the world. We wouldn’t want to be anywhere else – Ann Arbor offers a skilled base of scientific and engineering talent.”

NeuMoDx, Inc. will expand into 1100 E. Eisenhower Place.


About the Author: